Company news
Shield Therapeutics PLC news in 2017
Shield Therapeutics PLC's news releases, calls and decks from 2017, newest first.
Completion of patient enrolment in Phase 3 study
October 10, 2017
Interim Report
September 20, 2017
Board Change
September 14, 2017
US Composition of Matter Patent Allowed
September 6, 2017
Shield to Present at Baird Healthcare Conference
August 31, 2017
Grant of Share Options
July 11, 2017
Feraccru licence agreement for Switzerland
July 6, 2017
Warrant Exercise and Expiry
July 3, 2017
Admission of New Ordinary Shares
June 28, 2017
Biomarker data on ferric maltol in patients
June 22, 2017
Results of Fundraise
June 15, 2017
Annual Report, Accounts and AGM Notification
April 28, 2017
Appointment of Chief Financial Officer
April 4, 2017
IP Portfolio Update
March 13, 2017
Directorate and Secretarial Update
January 30, 2017